跳至主要内容
临床试验/EUCTR2019-002795-13-ES
EUCTR2019-002795-13-ES进行中(未招募)1 期

Identification of omic biomarkers and their inter and intra-individual variability that allow improvement in the individualization of tacrolimus: uncontrolled clinical trial in pediatric patients with renal transplantation.

Fundación de Investigación Hospital Universitario La Paz0 个研究点目标入组 180 人开始时间: 2020年2月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Subjects up to 18 years of age, both sexes included.
  • - Kidney transplants.
  • - Stable treatment with tacrolimus, as primary immunosuppressant, at the time of inclusion in the study. Stable treatment is considered when the variations in the last 3 determinations of tacrolimus levels are less than 30%, being these determinations a minimum of one week appart.
  • - Individuals who, previously informed, grant their consent to participate in the study.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 180
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Incapacity to understand the instructions or collaborate during the development of the study.
  • - Estimated glomerular filtration <30 mL / min / 1.73m2.
  • - Graft rejection or dysfunction in the previous 6 months.

研究者

发起方
Fundación de Investigación Hospital Universitario La Paz

相似试验